Both in Pharmaceuticals
Prothena vs Phathom Pharmaceuticals
Over the past year PRTA returned −21.2% and PHAT returned −57.6%; their daily moves had a correlation of 0.18.
PRTA −21.2% PHAT −57.6%Growth of $1, one year, split-adjusted
| Metric | PRTA | PHAT |
|---|---|---|
| Price | $8.47 | $5.74 |
| Market cap | $434.8M | $466.6M |
| Today | −4.62% | −7.72% |
| 1 month | −0.8% | −18.9% |
| 6 months | −20.4% | −52.2% |
| Year to date | −11.3% | −65.4% |
| 1 year | −20.5% | −57.6% |
| Revenue growth (YoY) | −77.1% | +71.1% |
| Gross margin | 100.0% | 78.3% |
| Net margin | −1839.9% | −16.4% |
| P/E (TTM) | — | — |
| Price / sales | 8.0× | 1.7× |
| Net cash | $288.2M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 46.5% | 71.7% |
| Short % of float | 18.9% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).